Response Pharmaceuticals

Falls Church, VA · Founded 2021 · Privately Held (backing)

Developer an intestinal microsomal triglyceride transfer protein inhibitor designed to treat the metabolic side effects of antipsychotic drugs. Response Pharmaceuticals is based in Falls Church, VA and was founded in 2021. It was valued at $30 million at its early-stage round in Nov 2025, the last priced event on record. It has raised $16.9 million across 2 recorded rounds; the latest was a $3.9 million debt round in Jun 2024.

PMV mark · valuation
$30.0M
Oct 2026
Priced at
its early-stage round
Nov 2025
Total raised
$16.9M
Last round
Debt
Jun 2024
How much has Response Pharmaceuticals raised?
$16.9Macross 2 recorded rounds · Feb 2022 – Jun 2024

Most recently, Response Pharmaceuticals raised $3.9M in its Debt (Jun 2024).

Free account
More of Response Pharmaceuticals with a free account
  • ·Watch Response Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Response Pharmaceuticals round by round

2 rounds
Jun 2024Debt$3.9MSEC filing▮
51 investors participated
Feb 2022Early Stage VC$8.0MSEC filing▮
127 investors participated

How much has Response Pharmaceuticals raised?

Response Pharmaceuticals has raised $16.9 million in total; 2 of its rounds are on record. The largest on record was an $8 million early-stage round in Feb 2022; the most recent was a $3.9 million debt round in Jun 2024.

Response Pharmaceuticals has filed 3 Form Ds with the SEC since 2022, most recently in Jun 2024 ($3.9 million sold to 51 investors).

Response Pharmaceuticals investors

6 investors are on record for Response Pharmaceuticals, including Evolution VC Partners, CrossWork, Collage Venture Partners and K2X. The debt round in Jun 2024 drew 51 investors.

For fundraisers
Raising for a company like Response Pharmaceuticals?

6 investors have backed Response Pharmaceuticals.

See all 6 investors →

Frequently asked about Response Pharmaceuticals

How much has Response Pharmaceuticals raised?
Response Pharmaceuticals has raised $16.9M in total across 2 recorded funding rounds.
When was Response Pharmaceuticals's last funding round?
Response Pharmaceuticals's most recent recorded round was Debt in Jun 2024, raising $3.9M.